ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Streck Cell-Free DNA BCT Receives FDA De Novo Clearance americanpharmaceuticalreview
September 18, 2020Streck Cell-Free DNA BCT received U.S. Food and Drug Administration (FDA) De Novo clearance for In Vitro Diagnostic use when paired with the Guardant360 CDx liquid biopsy assay.
Pharma Sources Insight January 2025
